KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $11.2 billion.

  • Biogen's Total Liabilities fell 132.88% to $11.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.2 billion, marking a year-over-year decrease of 132.88%. This contributed to the annual value of $11.2 billion for FY2025, which is 132.88% down from last year.
  • Latest data reveals that Biogen reported Total Liabilities of $11.2 billion as of Q4 2025, which was down 132.88% from $11.0 billion recorded in Q3 2025.
  • Biogen's Total Liabilities' 5-year high stood at $13.7 billion during Q3 2023, with a 5-year trough of $10.7 billion in Q2 2025.
  • In the last 5 years, Biogen's Total Liabilities had a median value of $11.7 billion in 2024 and averaged $11.9 billion.
  • Data for Biogen's Total Liabilities shows a peak YoY increase of 1345.29% (in 2023) and a maximum YoY decrease of 1907.78% (in 2023) over the last 5 years.
  • Biogen's Total Liabilities (Quarter) stood at $12.9 billion in 2021, then decreased by 13.56% to $11.2 billion in 2022, then increased by 7.88% to $12.0 billion in 2023, then fell by 5.91% to $11.3 billion in 2024, then dropped by 1.33% to $11.2 billion in 2025.
  • Its Total Liabilities stands at $11.2 billion for Q4 2025, versus $11.0 billion for Q3 2025 and $10.7 billion for Q2 2025.